These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 36859748)
1. Simplifying the Extended Clearance Concept Classification System (EC3S) to Guide Clearance Prediction in Drug Discovery. Patel M; Riede J; Bednarczyk D; Poller B; Deshmukh SV Pharm Res; 2023 Apr; 40(4):937-949. PubMed ID: 36859748 [TBL] [Abstract][Full Text] [Related]
2. Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS). Varma MV; Steyn SJ; Allerton C; El-Kattan AF Pharm Res; 2015 Dec; 32(12):3785-802. PubMed ID: 26155985 [TBL] [Abstract][Full Text] [Related]
3. Drug Design and Success of Prospective Mouse In Vitro-In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CL Manevski N; Umehara K; Parrott N Mol Pharm; 2023 Jul; 20(7):3438-3459. PubMed ID: 37235687 [TBL] [Abstract][Full Text] [Related]
4. Relationship between passive permeability, efflux, and predictability of clearance from in vitro metabolic intrinsic clearance. Huang L; Berry L; Ganga S; Janosky B; Chen A; Roberts J; Colletti AE; Lin MH Drug Metab Dispos; 2010 Feb; 38(2):223-31. PubMed ID: 19875499 [TBL] [Abstract][Full Text] [Related]
5. New IVIVE method for the prediction of total human clearance and relative elimination pathway contributions from in vitro hepatocyte and microsome data. Riede J; Poller B; Umehara K; Huwyler J; Camenisch G Eur J Pharm Sci; 2016 Apr; 86():96-102. PubMed ID: 26948853 [TBL] [Abstract][Full Text] [Related]
6. Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design. Di L; Keefer C; Scott DO; Strelevitz TJ; Chang G; Bi YA; Lai Y; Duckworth J; Fenner K; Troutman MD; Obach RS Eur J Med Chem; 2012 Nov; 57():441-8. PubMed ID: 22840492 [TBL] [Abstract][Full Text] [Related]
7. Predicting Clearance with Simple and Permeability-Limited Physiologically Based Pharmacokinetic Frameworks: Comparison of Well-Stirred, Dispersion, and Parallel-Tube Liver Models. Nagar S; Parise R; Korzekwa K Drug Metab Dispos; 2024 Sep; 52(10):1060-1072. PubMed ID: 39084881 [TBL] [Abstract][Full Text] [Related]
8. Application of the Extended Clearance Classification System (ECCS) in Drug Discovery and Development: Selection of Appropriate In Vitro Tools and Clearance Prediction. Umehara K; Cantrill C; Wittwer MB; Di Lenarda E; Klammers F; Ekiciler A; Parrott N; Fowler S; Ullah M Drug Metab Dispos; 2020 Oct; 48(10):849-860. PubMed ID: 32739889 [TBL] [Abstract][Full Text] [Related]
9. Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug-drug interactions. Camenisch G; Umehara K Biopharm Drug Dispos; 2012 May; 33(4):179-94. PubMed ID: 22407504 [TBL] [Abstract][Full Text] [Related]
10. Practical permeability-based hepatic clearance classification system (HepCCS) in drug discovery. Fan PW; Song Y; Berezhkovskiy LM; Cheong J; Plise EG; Khojasteh SC Future Med Chem; 2014; 6(18):1995-2012. PubMed ID: 25531965 [TBL] [Abstract][Full Text] [Related]
11. Evaluation and Optimization of a Microcavity Plate-Based Human Hepatocyte Spheroid Model for Predicting Clearance of Slowly Metabolized Drug Candidates. Kukla DA; Belair DG; Stresser DM Drug Metab Dispos; 2024 Jul; 52(8):797-812. PubMed ID: 38777596 [TBL] [Abstract][Full Text] [Related]
12. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay. Kosugi Y; Hosea N Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525 [TBL] [Abstract][Full Text] [Related]
13. Prediction of the intestinal first-pass metabolism of CYP3A and UGT substrates in humans from in vitro data. Nishimuta H; Sato K; Yabuki M; Komuro S Drug Metab Pharmacokinet; 2011; 26(6):592-601. PubMed ID: 21878741 [TBL] [Abstract][Full Text] [Related]
14. In Vitro - in Vivo Extrapolation of Hepatic Clearance in Preclinical Species. Tess DA; Ryu S; Di L Pharm Res; 2022 Jul; 39(7):1615-1632. PubMed ID: 35257289 [TBL] [Abstract][Full Text] [Related]
15. A New Guidance for the Prediction of Hepatic Clearance in the Early Drug Discovery and Development from the in Vitro-to-in Vivo Extrapolation Method and an Approach for Exploring Whether an Albumin-Mediated Hepatic Uptake Phenomenon Could be Present Under in Vivo Conditions. Poulin P; Haddad S J Pharm Sci; 2021 Jul; 110(7):2841-2858. PubMed ID: 33857483 [TBL] [Abstract][Full Text] [Related]
16. Use of intrinsic clearance for prediction of human hepatic clearance. Chao P; Uss AS; Cheng KC Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997 [TBL] [Abstract][Full Text] [Related]
17. Comparison of In Vitro to In Vivo Extrapolation Approaches for Predicting Transporter-Mediated Hepatic Uptake Clearance Using Suspended Rat Hepatocytes. Li N; Badrinarayanan A; Li X; Roberts J; Hayashi M; Virk M; Gupta A Drug Metab Dispos; 2020 Oct; 48(10):861-872. PubMed ID: 32759366 [TBL] [Abstract][Full Text] [Related]
18. Non-specific binding of compounds in Gardner I; Xu M; Han C; Wang Y; Jiao X; Jamei M; Khalidi H; Kilford P; Neuhoff S; Southall R; Turner DB; Musther H; Jones B; Taylor S Xenobiotica; 2022 Aug; 52(8):943-956. PubMed ID: 36222269 [TBL] [Abstract][Full Text] [Related]
19. Proof of Concept of an All-in-One System for Measuring Hepatic Influx, Egress, and Metabolic Clearance Based on the Extended Clearance Concept. Schulz Pauly JA; Sande E; Feng M; Wang YT; Stresser DM; Kalvass JC Drug Metab Dispos; 2024 Sep; 52(10):1048-1059. PubMed ID: 39095207 [TBL] [Abstract][Full Text] [Related]
20. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs. Poulin P J Pharm Sci; 2013 Jul; 102(7):2085-95. PubMed ID: 23613473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]